Your browser doesn't support javascript.
loading
Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.
Horton, Sarah J; Giotopoulos, George; Yun, Haiyang; Vohra, Shabana; Sheppard, Olivia; Bashford-Rogers, Rachael; Rashid, Mamunur; Clipson, Alexandra; Chan, Wai-In; Sasca, Daniel; Yiangou, Loukia; Osaki, Hikari; Basheer, Faisal; Gallipoli, Paolo; Burrows, Natalie; Erdem, Aysegül; Sybirna, Anastasiya; Foerster, Sarah; Zhao, Wanfeng; Sustic, Tonci; Petrunkina Harrison, Anna; Laurenti, Elisa; Okosun, Jessica; Hodson, Daniel; Wright, Penny; Smith, Ken G; Maxwell, Patrick; Fitzgibbon, Jude; Du, Ming Q; Adams, David J; Huntly, Brian J P.
Afiliación
  • Horton SJ; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Yun H; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Vohra S; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Sheppard O; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Bashford-Rogers R; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Rashid M; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Clipson A; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Chan WI; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Sasca D; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Yiangou L; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Osaki H; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Basheer F; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Gallipoli P; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Burrows N; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Erdem A; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Sybirna A; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
  • Foerster S; Department of Pathology, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
  • Zhao W; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Sustic T; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Petrunkina Harrison A; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Laurenti E; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Okosun J; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Hodson D; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Wright P; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Smith KG; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Maxwell P; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Fitzgibbon J; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
  • Du MQ; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Adams DJ; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Huntly BJP; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
Nat Cell Biol ; 19(9): 1093-1104, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28825697
ABSTRACT
Loss-of-function mutations of cyclic-AMP response element binding protein, binding protein (CREBBP) are prevalent in lymphoid malignancies. However, the tumour suppressor functions of CREBBP remain unclear. We demonstrate that loss of Crebbp in murine haematopoietic stem and progenitor cells (HSPCs) leads to increased development of B-cell lymphomas. This is preceded by accumulation of hyperproliferative lymphoid progenitors with a defective DNA damage response (DDR) due to a failure to acetylate p53. We identify a premalignant lymphoma stem cell population with decreased H3K27ac, which undergoes transcriptional and genetic evolution due to the altered DDR, resulting in lymphomagenesis. Importantly, when Crebbp is lost later in lymphopoiesis, cellular abnormalities are lost and tumour generation is attenuated. We also document that CREBBP mutations may occur in HSPCs from patients with CREBBP-mutated lymphoma. These data suggest that earlier loss of Crebbp is advantageous for lymphoid transformation and inform the cellular origins and subsequent evolution of lymphoid malignancies.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Transformación Celular Neoplásica / Proteína de Unión a CREB / Células Progenitoras Linfoides / Linfoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cell Biol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Transformación Celular Neoplásica / Proteína de Unión a CREB / Células Progenitoras Linfoides / Linfoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cell Biol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido